• PDK4-IN-1 Hydrochloride: Uncovering Metabolic Reprogramming

  2026-05-27

  Explore how PDK4-IN-1 hydrochloride, a selective pyruvate dehydrogenase kinase 4 inhibitor, enables targeted metabolic reprogramming. This article uniquely dissects the mechanistic, translational, and experimental nuances shaping next-generation metabolism research.

• Tamsulosin for Urological Research: Protocols, Pitfalls, and

  2026-05-27

  Tamsulosin’s role as a highly selective α₁A-adrenergic receptor antagonist enables research teams to dissect smooth muscle relaxation and GPCR signaling with unmatched accuracy. This guide translates cutting-edge evidence and robust protocol design into actionable workflows for urological disease research, with troubleshooting tips and cross-domain insights.

• Targeting GOT1 to Disrupt Redox Homeostasis in Pancreatic Ca

  2026-05-26

  This study identifies ziprasidone as a novel non-competitive inhibitor of GOT1, demonstrating its ability to disrupt glutamine metabolism and redox regulation in pancreatic ductal adenocarcinoma (PDAC) cells. The findings highlight a potential therapeutic strategy for PDAC by targeting metabolic vulnerabilities associated with redox balance.

• CCK-8s Activates NOX4–PGC-1α–PPAR Pathway to Regulate ANP Se

  2026-05-26

  This study reveals that sulfated cholecystokinin octapeptide (CCK-8s) triggers atrial natriuretic peptide (ANP) secretion in isolated rat atria via the NOX4–PGC-1α–PPARα/γ axis. These findings clarify the molecular mechanisms linking neuropeptide signaling, reactive oxygen species (ROS), and cardiovascular regulation, with implications for inflammation and cardiac research.

• Synthetic Viability with ERCC1 Deficiency in Lung Cancer: Me

  2026-05-25

  Heyza et al. (2019) identified a synthetic viable phenotype in ERCC1-deficient lung cancer cells exposed to DNA crosslinking agents, revealing that p53 status crucially modulates cisplatin sensitivity and apoptotic response. These findings refine our understanding of DNA repair pathways and highlight key variables influencing biomarker utility and treatment outcomes in platinum-based chemotherapy.

• 5-hme-dCTP: Enhancing Epigenetic DNA Modification Workflows

  2026-05-25

  Unlock sensitive, high-resolution epigenetic DNA modification research using 5-hme-dCTP. This guide delivers actionable protocols, troubleshooting insights, and workflow enhancements for reliable gene regulation and plant drought response studies.

• Glucocorticoid Receptor Controls Hippocampal CYPs and Neurop

  2026-05-24

  This study reveals that pregnenolone 16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 (CYP) enzymes and attenuates phenytoin-induced neurotoxicity via a glucocorticoid receptor-dependent, pregnane X receptor (PXR)-independent pathway. These findings challenge conventional assumptions about nuclear receptor regulation of brain CYPs and suggest new therapeutic avenues for mitigating adverse neurological effects of antiepileptic drugs.

• MDL 28170: Selective Calpain and Cathepsin B Inhibition in t

  2026-05-23

  This article addresses key laboratory challenges in cell viability, neuroprotection, and cytotoxicity assays by exploring validated, scenario-driven applications of MDL 28170, Calpain and Cathepsin B Inhibitor, Selective (SKU A4412). Drawing on peer-reviewed data, it guides researchers in optimizing assay reproducibility and interpreting mechanistic outcomes using this reference-grade, cell-permeable inhibitor.

• Novel Allosteric PDK4 Inhibitors: Insights for Metabolic Dis

  2026-05-22

  This article reviews the innovative discovery of potent allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, particularly compound 8c, for metabolic disease intervention. The findings open pathways for targeted modulation of metabolic and immune processes, with translational relevance for diabetes, allergy, and cancer research.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina

  2026-05-22

  This study reveals gramine's novel mechanism in suppressing triple-negative breast cancer (TNBC) by inducing ferroptosis through CUL3-mediated ubiquitination of MTDH. These findings highlight the therapeutic promise of natural alkaloids in targeting chemoresistant TNBC and elucidate a new axis in ferroptosis regulation.

• TaqI Restriction Endonuclease: Fast DNA Cleavage for Researc

  2026-05-21

  TaqI Restriction Endonuclease (SKU K3053) enables rapid and efficient sequence-specific cleavage of plasmid, PCR, or genomic DNA. It is optimized for research workflows needing fast sticky-end generation, but is not suitable for diagnostic or clinical use. Use is limited to scientific research applications where speed and precision in DNA digestion are required.

• Dopamine Transporter Imaging Tracks Neuron Maturation in PD

  2026-05-21

  Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging enables reliable, non-invasive assessment of the maturation of human embryonic stem cell-derived dopaminergic neurons in preclinical Parkinson’s disease (PD) models. This approach correlates closely with histological differentiation, offering a robust method for evaluating cell therapy efficacy and early post-transplant maturation.

• Praeruptorin A: Angular Pyranocoumarin Compound in Translati

  2026-05-20

  Praeruptorin A empowers inflammation, ferroptosis, and cancer metastasis research with multi-pathway precision and reliable safety. This article unpacks essential workflows, protocol tips, and troubleshooting strategies, helping preclinical investigators maximize assay fidelity and translational relevance.

• Abiraterone Acetate: Benchmark CYP17 Inhibitor for Prostate

  2026-05-20

  Abiraterone acetate is a potent, selective CYP17 inhibitor widely used in prostate cancer research. Its unique 3β-acetate prodrug form enhances solubility and cellular uptake, enabling robust androgen biosynthesis pathway inhibition. This article delivers evidence-backed parameters, practical workflow integration, and clarifies clinical research boundaries.

• Ionomycin Calcium Salt: Unveiling Calcium Ionophore Roles in

  2026-05-19

  Explore the advanced science of Ionomycin calcium salt, a leading calcium ionophore, in modulating ribosome biogenesis and cancer cell survival. This article uniquely bridges calcium signaling and translational control, offering mechanistic insights beyond standard apoptosis assays.

456 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page